# Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

> **NCT05284643** · NA · RECRUITING · sponsor: **University of Miami** · enrollment: 96 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **RADIATION:** Intensity Modulated Proton Therapy (IMPT)
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT05284643
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05284643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05284643, "Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05284643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*